Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients

[1]  F. Gioia,et al.  Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate , 2019, Reumatología Clínica (English Edition).

[2]  J. Bachiller-Corral,et al.  Leishmaniasis visceral en un paciente con artritis reumatoide en tratamiento con metotrexato , 2017, Reumatología Clínica.

[3]  N. Vallianou,et al.  Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature. , 2017, European journal of rheumatology.

[4]  Jamie L. Cross,et al.  Current , 2017 .

[5]  F. Gioia,et al.  Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate. , 2017, Reumatologia clinica.

[6]  R. López-Vélez,et al.  Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Marta Hernández,et al.  Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab. , 2015, Gastroenterologia y hepatologia.

[8]  Antonio Vallecillo,et al.  Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  C. Perales,et al.  Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review , 2014, International journal of rheumatic diseases.

[10]  D. Anyfantakis,et al.  Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate. , 2014, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[11]  L. Lynen,et al.  Visceral Leishmaniasis and HIV Coinfection in East Africa , 2014, PLoS neglected tropical diseases.

[12]  R. López-Vélez,et al.  Leishmaniasis in immunosuppressed individuals. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  R. López-Vélez,et al.  Leishmaniasis acquired by travellers to endemic regions in Europe: a EuroTravNet multi-centre study. , 2014, Travel medicine and infectious disease.

[14]  G. Kang,et al.  Louse Infestation in Manson's Tropical Diseases (23rd Ed.) , 2014 .

[15]  D. Lockwood,et al.  Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists. , 2013, Travel medicine and infectious disease.

[16]  U. Müller-Ladner,et al.  Current immunotherapy in rheumatoid arthritis. , 2013, Immunotherapy.

[17]  A. Perez,et al.  Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  C. Ravel,et al.  Heat-shock protein 70 gene sequencing for Leishmania species typing in European tropical infectious disease clinics. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  J. Tsai,et al.  Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis , 2013, The Medical journal of Australia.

[20]  P. Kremsner,et al.  Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  C. Bogdan.  Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats , 2012, Annals of the rheumatic diseases.

[22]  H. Körner,et al.  The role of TNF in parasitic diseases: still more questions than answers. , 2010, International journal for parasitology.

[23]  P. Ready.  Leishmaniasis emergence in Europe. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[24]  J. Martín‐Sánchez,et al.  Canine Leishmaniasis in Southeastern Spain , 2009, Emerging infectious diseases.

[25]  A. Zimmermann,et al.  Holiday souvenirs from the Mediterranean: Three instructive cases of visceral leishmaniasis , 2009, Scandinavian journal of infectious diseases.

[26]  J. Alvar,et al.  Complexities of Assessing the Disease Burden Attributable to Leishmaniasis , 2008, PLoS neglected tropical diseases.

[27]  S. Antinori,et al.  Leishmaniasis among organ transplant recipients. , 2008, The Lancet. Infectious diseases.

[28]  P. Narciso,et al.  Leishmania infantum leishmaniasis in corticosteroid – treated patients , 2006, BMC infectious diseases.

[29]  K. Hongo,et al.  A case report and review of the literature , 2006, Journal of Neuro-Oncology.

[30]  N. Mühlberger,et al.  Imported leishmaniasis in Germany 2001–2004: data of the SIMPID surveillance network , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[31]  I. Suffia,et al.  Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniosis in chronically infected BALB/c mice. , 1999 .

[32]  E. Sondorp,et al.  The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. , 1996, International journal of epidemiology.

[33]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.

[34]  William F. Hughes,et al.  Manson's Tropical Diseases , 1914, The Indian Medical Gazette.